key: cord-0824231-9h26mj7w
authors: Wang, Jinfeng; Li, Ruiwen; Sun, Xiaoxia; Liu, Libing; Hao, Xuepiao; Wang, Jianchang; Yuan, Wanzhe
title: Development and validation of the isothermal recombinase polymerase amplification assays for rapid detection of Mycoplasma ovipneumoniae in sheep
date: 2020-06-01
journal: BMC Vet Res
DOI: 10.1186/s12917-020-02387-3
sha: 11ea9de737ef39690df22188f4727fdd0e8b749e
doc_id: 824231
cord_uid: 9h26mj7w

BACKGROUND: Mycoplasmal pneumonia is an important infectious disease that threatens sheep and goat production worldwide, and Mycoplasma ovipneumoniae is one of major etiological agent causing mycoplasmal pneumonia. Recombinase polymerase amplification (RPA) is an isothermal nucleic acid amplification technique, and RPA-based diagnostic assays have been described for the detection of different types of pathogens. RESULTS: The RPA assays using real-time fluorescence detection (real-time RPA) and lateral flow strip detection (LFS RPA) were developed to detect M. ovipneumoniae targeting a conserved region of the 16S rRNA gene. Real-time RPA was performed in a portable florescence scanner at 39 °C for 20 min. LFS RPA was performed in a portable metal bath incubator at 39 °C for 15 min, and the amplicons were visualized with the naked eyes within 5 min on the lateral flow strip. Both assays were highly specific for M. ovipneumoniae, as there were no cross-reactions with other microorganisms tested, especially the pathogens involved in respiratory complex and other mycoplasmas frequently identified in ruminants. The limit of detection of LFS RPA assay was 1.0 × 10(1) copies per reaction using a recombinant plasmid containing target gene as template, which is 10 times lower than the limit of detection of the real-time RPA and real-time PCR assays. The RPA assays were further validated on 111 clinical sheep nasal swab and fresh lung samples, and M. ovipneumoniae DNA was detected in 29 samples in the real-time RPA, 31 samples in the LFS RPA and 32 samples in the real-time PCR assay. Compared to real-time PCR, the real-time RPA and LFS RPA showed diagnostic specificity of 100 and 98.73%, diagnostic sensitivity of 90.63 and 93.75%, and a kappa coefficient of 0.932 and 0.934, respectively. CONCLUSIONS: The developed real-time RPA and LFS RPA assays provide the attractive and promising tools for rapid, convenient and reliable detection of M. ovipneumoniae in sheep, especially in resource-limited settings. However, the effectiveness of the developed RPA assays in the detection of M. ovipneumoniae in goats needs to be further validated.

Mycoplasma ovipneumoniae is one of the major pathogens that cause mycoplasma pneumonia in sheep, goats, and wild ruminants [1] [2] [3] [4] [5] . M. ovipneumoniae-associated respiratory disease is characterized by cough, gasp, runny noses, progressive weight loss, pulmonary interstitial hyperplasia inflammation, and variable morbidity and mortality rates between flocks [6, 7] . Moreover, upon M. ovipneumoniae infection, sheep and goats become susceptible to other common pathogens causing respiratory disease, such as Mannheimia haemolytica, Pasteurella multocida and Parainfluenza-3 virus [8, 9] . Since first confirmed in Australia in 1972, infections by M. ovipneumoniae have been an endemic problem worldwide and have caused severe economic losses to the sheep and goat industry [10] [11] [12] .

Bacteriological culture of M. ovipneumoniae is currently the gold standard for diagnosis, however, the culture is cumbersome and time-consuming due to the fastidious nature of the bacterium as well as that the follows required species identification by biochemical or serological tests, which make the assay burdensome for the routine applications [13] [14] [15] . In addition, the bacterial isolation may be hampered by sample contamination and prior antibiotic treatments received by the diseased animals. Serological tests, such as ELISA, indirect hemagglutination assay, are the common and economic methods for M. ovipneumoniae herd surveillance [12, 16] . However, seroconversion to M. ovipneumoniae is often delayed after natural infection, which makes the serology less effective in detecting early-stages of infection in herds, and unsuitable for detecting acute mycoplasmal pneumonia in the field [9, 14] . It is an urgent need to develop a rapid and accurate method to detect M. ovipneumoniae. Different nucleic acid amplificationbased methods have been described to be sensitive and specific for M. ovipneumoniae, i.e. PCR, real-time PCR, and loop-mediated isothermal amplification (LAMP) [9, 14, 15] . PCR assays require a well-equipped laboratory, expensive equipment and trained personnel, which limits their application in the under-equipped laboratories and the point-of-need (PON) diagnosis [9, 15] . Compared to the PCR assays, the isothermal amplification methods have advantages regarding convenience to perform and minimal equipment requirement. A LAMP assay for the detection of M. ovipneumoniae has been described for low requirement of experimental conditions, however, the assay requires 60 min to complete the reaction [14] .

Recombinase polymerase amplification (RPA), an isothermal DNA amplification technique, is rapid, reliable and considered to be a promising approach for PON diagnosis [17, 18] . RPA-based diagnostic assays have been described for the detection of different pathogens from different clinical samples [19, 20] . In this study, a real-time RPA assay using the exo probe and a LFS RPA assay using the nfo probe combined with lateral flow strip were developed for rapid, specific and sensitive detection of M. ovipneumoniae. The performance of the assays was further assessed by collecting and detecting the clinical sheep nasal swab and lung samples.

Analytical specificity and sensitivity of the RPA assays Only M. ovipneumoniae was amplified in both real-time RPA and LFS RPA assays (Fig. 1) . The specificity analysis was repeated five times with similar results, which demonstrated the good repeatability of the RPA assays.

The limit of detection of LFS RPA assay was 1.0 × 10 1 copies M. ovipneumoniae standard DNA per reaction ( Fig. 2a) , while the LOD of real-time RPA was 1.0 × 10 2 copies per reaction (Fig. 2b) , which was same as that of the real-time PCR (data not shown). The real-time RPA assay was further performed eight times on the standard DNA, and 1.0 × 10 7 -1.0 × 10 2 copies DNA molecules were detected in 8/8 runs, 1.0 × 10 1 -1.0 × 10 0 , 0/8, which demonstrated the good reproducibility (Fig. 3) .

Of the 111 sheep clinical samples, M. ovipneumoniae DNA was detected in 29 (26.12%), 31 (27.93%) and 32 (28.83%) samples by the real-time RPA, LFS RPA and real-time PCR, respectively (Table 1 ). Compared to the real-time PCR assay, the real-time RPA assay and LFS RPA assay showed diagnostic specificity (DSp) of 100 and 98.73%, diagnostic sensitivity (DSe) of 90.63 and 93.75%, positive predictive value (PPV) of 100 and 96.77%, negative predictive value (NPV) of 96.34 and 97.5%, and kappa value of 0.932 and 0.934, respectively ( Table 2 ). The real-time RPA and LFS RPA assays demonstrated the comparable performance in detecting the 111 sheep clinical samples. In the RPA assays, it took no more than 20 min to obtain the positive results, while it need approximately 32 min -46 min in the real-time PCR with the Ct values ranging from 20.77 to 36.52.

The developed real-time RPA and LFS RPA assays are highly specific and sensitive for detection of M. ovipneumoniae in the sheep clinical samples. Both RPA assays performed well at 39°C within 20 min, which is faster than other common nucleic acid amplification methods. The real-time RPA assay and LFS RPA assay were performed on the tube scanner Genie III and a metal bath incubator, respectively. These two pieces of equipment are portable, lightweight, easily carried and can be charged by battery for working a whole day. For the RPA reagents, they are provided in the form of lyophilized powder and are independent of cold chains. Several studies also demonstrated that RPA was tolerant to most of the PCR inhibitors [19, 21] . The above characteristics make the developed RPA assays ideal for the detection of M. ovipneumoniae in field which is especially important for farms located in rural areas.

The PCR and LAMP assays targeted on the 16S rRNA gene, elongation factor TU gene or adhesin P113 gene had demonstrated their efficacy in the detection of M. ovipneumoniae in different clinical specimens, including the nasal swabs and lung samples [4, 9, 14, 15] . The RPA primers and probes were designed basing on the 16S rRNA gene of M. ovipneumoniae in this study. To ensure that the target sequences were unique to M. ovipneumoniae, we screened the selected primers and probes in silico using the pattern searching tool function from the EMBOSS package against the genomes of the common mycoplasmas causing infections in ruminants [22] . The complementary regions could not be found when allowing 1 or 5 sequence mismatches for the primer sequences. Furthermore, there was no mismatch in the reverse primers and probes in the M. ovipneumoniae strains available in Genbank, and only one mismatch in the forward primer in two strains: 2013-12,928-46 (Accession number: MN028079) and NCTC10151 (Accession number: LR215028.1). According to the above in silico analysis, the designed primers and probes fulfilled the specificity requirements of RPA [23] . In the specificity analysis, both the real-time RPA and LFS RPA only amplified the genomic DNA of M. ovipneumoniae, and no other mycoplasmas, bacteria and PPRV. Most importantly, M. capricolum subsp. capripneumoniae, the etiological agent of contagious caprine pleuropneumonia, was not amplified by the new developed RPA assays. Although the in silico sequence analysis support that all the M. ovipneumoniae strains are detectable, more genomic DNA of different strains of M. ovipneumoniae should be tested for further confirmation.

With the real-time PCR as the reference assay, the diagnostic performances of the developed real-time RPA and LFS RPA assays were evaluated. The performances of the RPA assays were comparable to the real-time PCR, while the RPA assays were faster to obtain the detection results. Furthermore, the developed real-time RPA was slightly weak in the detection of the clinical samples containing low amounts of M. ovipneumoniae DNA, as three nasal samples were negative in real-time RPA assay while positive in real-time PCR with Ct values of 36.49, 35.50 and 36.52. The above results are 

In this study, we describe the development of the realtime RPA and LFS RPA assays for the simple, rapid and 

To generate a M. ovipneumoniae standard DNA for the RPA assays, a PCR product containing 361 bp covering the region of interest of 16S rRNA gene was amplified from the M. ovipneumoniae DNA using LMF1 and LMR1 as primers (Table 3 ) and cloned into the pMD19-T (Takara, Dalian, China) for standards. The resulting plasmid, pMO-16SrRNA, was transformed into Escherichia coli DH5α cells, purified with the SanPrep Plasmid MiniPrep Kit (Sangon Biotech, Shanghai, China) and quantified. The copy number of DNA molecules was calculated by the following formula: amount (copies/ μL) = [DNA concentration (g/μL)/ (plasmid length in base pairs× 660)] × 6.02 × 10 23 . Ten-fold dilutions of the pMO-16SrRNA, ranging from 1.0 × 10 7 to 1.0 × 10 0 copies/μL, were prepared in nuclease-free water and aliquots of each dilution were stored at − 80°C.

The 16S rRNA gene of M. ovipneumoniae was determined as the amplification target for RPA. According to the reference sequences of M. ovipneumoniae (Accession numbers: NR_025989.1, LR215028.1, MN028361, MN028184, MN028079, MH133233), the highly conserved region in the 16S rRNA gene was identified, and the RPA primers, exo and nfo probes were designed following the RPA manufacturer guidelines (TwistDx. Cambridge, UK). Primers and probe are listed in Table 3 and synthesized by a commercial company (Sangon Biotech, Shanghai, China).

The M. ovipneumoniae real-time RPA assay was performed as described previously [24] . The total reaction volume was 50 μL including 40.9 μL of Buffer A (rehydration buffer), 2.0 μL of each RPA primers (MO-exo-F and MO-exo-R, 10 μmol/L), 0.6 μL of exo probe (MO-exo-P, 10 μmol/L) and 2.5 μL of Buffer B (magnesium acetate, 280 mmol/L). Furthermore, 1 μL of genomic DNA or recombinant plasmid was used for the specificity and sensitivity analysis, or 2 μL of sample DNA was used for the clinical sample diagnosis. The M. ovipneumoniae LFS RPA assay was also performed as described previously [24] . The total reaction volume was 50 μL including 29.5 μL of rehydration buffer, 2.1 μL of each RPA primers (MO-nfo-F and MOnfo-R, 10 μmol/L), 0.6 μL of exo probe (MO-nfo-P, 10 μmol/L) and 2.5 μL of magnesium acetate (280 mmol/ L). In addition, 1 μL of bacterial genomic DNA or recombinant plasmid was used for the specific and sensitive analysis, or 2 μL of sample DNA was used for the clinical sample diagnosis. The assay was performed in a metal bath incubator at 39°C for 15 min. Furthermore, the lateral flow strips (Milenia Biotec GmbH, Germany) were used to detect the RPA amplicons dual-labeled with FAM and biotin.

Both RPA assays were performed to amplify the nucleic acids of a panel of microorganisms including M. ovipneumoniae, flocculare, M. haemolytica, P. multocida, K. pneumoniae, PPRV, which are considered to be dangerous to the sheep and goat respiratory system or frequently identified in the ruminants. The analytical specificity analysis was repeated five times.

The standard DNA of M. ovipneumoniae, ranging from 1.0 × 10 7 to 1.0 × 10 0 copies/μL, was used for the RPA analytical sensitivity analysis. One microliter of each dilution was amplified by both RPA assays to determine the limit of detection (LOD). The analytical sensitivity analysis was repeated five times. Furthermore, the real-time RPA was tested using the standard DNA in 8 replicates, the threshold time was plotted against the molecules detected and a semi-log regression was calculated using Prism software 5.0 (Graphpad Software Inc., SanDiego, California).

The RPA assays were validated with 95 sheep nasal swabs and 16 sheep fresh lungs. All samples tested with the two RPA assays were also tested by a real-time PCR in parallel. The real-time PCR for M. oviopneumoniae was performed on a ABI 7500 instrument (Applied Biosystems, Foster City, California), which was described previously [4] . 

Chronic non-progressive pneumonia of sheep in New Zealand -a review of the role of mycoplasma ovipneumoniae

Mycoplasma ovipneumoniae in wildlife species beyond subfamily Caprinae

Mycoplasma ovipneumoniae infection in Zimbabwean goats and sheep

Mycoplasma ovipneumoniae--a primary cause of severe pneumonia epizootics in the Norwegian muskox (Ovibos moschatus) population

Mycoplasmas of goats and sheep

Association of Mycoplasma ovipneumoniae infection with population-limiting respiratory disease in free-ranging Rocky Mountain bighorn sheep (Ovis canadensis canadensis)

Mycoplasma ovipneumoniae associated with severe respiratory disease in goats

An aetiopathological study of chronic bronchopneumonia in lambs in Ireland

Detection of mycoplasma ovipneumoniae in Pasteurella-vaccinated sheep flocks with respiratory disease in England

Isolation, propagation, and characterization studies of an ovine mycoplasma responsible for proliferative interstitial pneumonia

Seroepidemiological survey of sheep flocks from northern Japan for mycoplasma ovipneumoniae and mycoplasma agalactiae

Serological and molecular survey of sheep infected with mycoplasma ovipneumoniae in Xinjiang

Detection of mycoplasma ovipneumoniae and M. arginini in bighorn sheep using enrichment culture coupled with genus-and species-specific polymerase chain reaction

Loop-mediated isothermal amplification-lateral-flow dipstick (LAMP-LFD) to detect mycoplasma ovipneumoniae

A realtime PCR for detection and quantification of mycoplasma ovipneumoniae

Seroprevalence and molecular detection of mycoplasma ovipneumoniae in goats in tropical China

DNA detection using recombination proteins

A new approach for diagnosis of bovine coronavirus using a reverse transcription recombinase polymerase amplification assay

Recombinase polymerase amplification for diagnostic applications

Review: a comprehensive summary of a decade development of the recombinase polymerase amplification

Factors influencing Recombinase polymerase amplification (RPA) assay outcomes at point of care

EMBOSS: the European molecular biology open software suite

Influence of sequence mismatches on the specificity of recombinase polymerase amplification technology

Rapid and sensitive detection of mycoplasma hyopneumoniae by recombinase polymerase amplification assay

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

The authors thank the laboratory staff in the animal hospital of Hebei Agricultural University. We also thank Dr. Qingan Han from the Hebei Animal Disease Prevention and Control Center for providing the 65 nucleic acid samples.

Authors' contributions JCW and WZY conceived and designed the study. JFW and RWL developed the real-time RPA and LFS RPA assays and analyzed the data. XXS, LBL and XPH performed the clinical samples testing, helped in the data analysis and manuscript revision. JCW and WZY wrote the manuscript. All authors read and approved the final manuscript. Agro-industry Technology Research System (HBCT2018140204). The funding agencies had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.

The dataset analyzed during the current study is available from the corresponding author on reasonable request. The nucleotide sequences under the relevant accession numbers (CP007154, NR_044773, NR_118796, NR_025182, NR_025989.1, LR215028.1, MN028361, MN028184, MN028079, MH133233, MN028079, LR215028.1) analysed during the current study are available in the GenBank repository, https://www.ncbi.nlm.nih.gov/nuccore/.

The sheep nasal swabs and sheep fresh lungs used in this study were collected in sheep husbandry farms and a slaughter house, respectively. The written consents for the use of the samples before participation in the study were obtained from the farmers and the slaughter house's owner. This study was approved by the Institutional Animal Care and Ethics Committee of Hebei Agricultural University (approval no. IACECHEBAU20110509).

Not applicable.

The authors declare that they have no competing interests.